Building genetic assessments into how we determine prognosis of ALL
Ponatinib and its role in treating ALL
Dr Moorman's highlights on mixed phenotype acute leukemia (MPAL) from ASH 2016
Chemo-free approach in acute promyelocytic leukemia (APL) treatment
Can genetic abnormalities be targeted in MM?